121 related articles for article (PubMed ID: 11767003)
1. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma.
Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Shan L; Suzuma T; Tamaki T; Umemura T; Mori I; Kakudo K
Breast Cancer Res Treat; 2001 Nov; 70(1):39-45. PubMed ID: 11767003
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma.
Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K
Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer.
Qiu H; Lotan R; Lippman SM; Xu XC
Genes Chromosomes Cancer; 2000 Jun; 28(2):196-202. PubMed ID: 10825004
[TBL] [Abstract][Full Text] [Related]
4. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.
Widschwendter M; Berger J; Hermann M; Müller HM; Amberger A; Zeschnigk M; Widschwendter A; Abendstein B; Zeimet AG; Daxenbichler G; Marth C
J Natl Cancer Inst; 2000 May; 92(10):826-32. PubMed ID: 10814678
[TBL] [Abstract][Full Text] [Related]
5. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
6. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer.
Picard E; Seguin C; Monhoven N; Rochette-Egly C; Siat J; Borrelly J; Martinet Y; Martinet N; Vignaud JM
J Natl Cancer Inst; 1999 Jun; 91(12):1059-66. PubMed ID: 10379969
[TBL] [Abstract][Full Text] [Related]
7. Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer.
Yang Q; Mori I; Shan L; Nakamura M; Nakamura Y; Utsunomiya H; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Sakurai T; Kakudo K
Am J Pathol; 2001 Jan; 158(1):299-303. PubMed ID: 11141504
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss of chromosomal arm 8p in breast cancer progression.
Anbazhagan R; Fujii H; Gabrielson E
Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
10. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
[TBL] [Abstract][Full Text] [Related]
11. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.
Widschwendter M; Berger J; Müller HM; Zeimet AG; Marth C
J Mammary Gland Biol Neoplasia; 2001 Apr; 6(2):193-201. PubMed ID: 11501579
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.
Iobagiu C; Lambert C; Raica M; Lima S; Khaddage A; Peoc'h M; Genin C
Cancer Genet; 2015 Apr; 208(4):135-42. PubMed ID: 25979597
[TBL] [Abstract][Full Text] [Related]
14. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of retinoic acid receptor β2 gene in the initiation of breast cancer.
Sun J; Xu X; Liu J; Liu H; Fu L; Gu L
Med Oncol; 2011 Dec; 28(4):1311-8. PubMed ID: 20865461
[TBL] [Abstract][Full Text] [Related]
16. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.
Widschwendter M; Berger J; Daxenbichler G; Müller-Holzner E; Widschwendter A; Mayr A; Marth C; Zeimet AG
Cancer Res; 1997 Oct; 57(19):4158-61. PubMed ID: 9331065
[TBL] [Abstract][Full Text] [Related]
17. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
[TBL] [Abstract][Full Text] [Related]
18. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients.
Ismail HM; Medhat AM; Karim AM; Zakhary NI
Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer.
Matsumoto S; Minobe K; Utada Y; Furukawa K; Onda M; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer Lett; 2000 Apr; 152(1):63-9. PubMed ID: 10754207
[TBL] [Abstract][Full Text] [Related]
20. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
